Objectives: To review signs and symptoms in children diagnosed with meningo
coccal infection: to assess age, sex and race distribution of meningococcal
infection, and to assess associations of the presenting features with morb
idity and mortality,
Design: Retrospective case notes review for a 5-year period.
Subjects: 105 patients aged between 19 days and 13 years.
Main data reviewed: Temperature, blood pressure, heart rate, respiratory ra
te, type of rash, age, sex, race and outcome.
Results: Of the 105 patients, 67.6% were Caucasian, 27.6% aboriginal and 4.
8% of other origin. There were 14.3% patients under 3 months of age (2.9% n
eonates), 48.6% between 3 months and 2 years, 21% between 2 and 4 years and
16.2% older than 4 years, The male:female ratio was 1.4. Features at prese
ntation in decreasing order of frequency were: fever (89.5%), tachypnoea (7
3.3%), rash (59% [maculopapular 17.1%, petechial 27.6% and purpuric 14.3%])
, vomiting (52.4%), irritability (44.8%), tachycardia (37.5%), lethargy (36
.2%), neck stiffness (32.4%) and non-specific immediately preceding illness
(15.2%). Purpura and a reduced systolic blood pressure were significantly
associated with an increased risk of mortality, purpura and reduced diastol
ic blood pressure with an increased risk of morbidity, Initial misdiagnosis
occurred in 17.1% of cases, with the majority of those misdiagnosed (83.3%
) aged less than 2 years. Predominant serotyping was Group B followed by Gr
oup C. Major findings were a marked male preponderance in patients under 3
months of age, The incidence of meningococcal infection in the Aboriginal p
opulation was approximately six times that in the non-Aboriginal population
. The yearly incidence of meningococcal disease during the study period ran
ged from 5.2 to 10,5 per 100.000. Long-term morbidity occurred in 8.6% of c
ases and mortality was 8.6%. Higher morbidity and mortality figures were fo
und in those with septicaemia alone. Children referred from peripheral hosp
itals had a higher mortality but a comparable morbidity.